Judge accepts CVS offer on Aetna while reviewing consent decree By Reuters

WASHINGTON (Reuters) – A U.S. federal judge reviewing an agreement between the government and CVS Health Corp (N:) allowing it to buy health insurer Aetna (NYSE:) has indicated that he will not halt most integration between the two companies.

Judge Richard Leon said in an order on Friday evening that he would accept CVS’s offer to allow Aetna to independently make critical product, pricing and personnel decisions during his review.

“Based on CVS’s constructive and appropriate representations, I am satisfied that, so long as these measures remain in place, the assets involved in the challenged acquisition will remain sufficiently separate (during the review period),” Leon wrote in his order.

The Justice Department approved the $69 billion merger of CVS, a U.S. pharmacy chain and benefits manager, and Aetna in October on condition that Aetna sell its Medicare prescription drug plan business to WellCare Health Plans Inc (N:). Both deals have closed.

Antitrust consent decrees are usually approved without much fanfare but Leon has said that he was “less convinced” than the government that the agreement would resolve antitrust concerns.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.